Cargando…
Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
Mutations in presenilin 1 and 2 (PS1 and PS2) cause autosomal dominant familial Alzheimer’s disease (FAD). Ferroptosis has been implicated as a mechanism of neurodegeneration in AD since neocortical iron burden predicts Alzheimer’s disease (AD) progression. We found that loss of the presenilins dram...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613996/ https://www.ncbi.nlm.nih.gov/pubmed/35449212 http://dx.doi.org/10.1038/s41418-022-01003-1 |
_version_ | 1784820095875284992 |
---|---|
author | Greenough, Mark A. Lane, Darius J. R. Balez, Rachelle Anastacio, Helena Targa Dias Zeng, Zhiwen Ganio, Katherine McDevitt, Christopher A. Acevedo, Karla Belaidi, Abdel Ali Koistinaho, Jari Ooi, Lezanne Ayton, Scott Bush, Ashley I. |
author_facet | Greenough, Mark A. Lane, Darius J. R. Balez, Rachelle Anastacio, Helena Targa Dias Zeng, Zhiwen Ganio, Katherine McDevitt, Christopher A. Acevedo, Karla Belaidi, Abdel Ali Koistinaho, Jari Ooi, Lezanne Ayton, Scott Bush, Ashley I. |
author_sort | Greenough, Mark A. |
collection | PubMed |
description | Mutations in presenilin 1 and 2 (PS1 and PS2) cause autosomal dominant familial Alzheimer’s disease (FAD). Ferroptosis has been implicated as a mechanism of neurodegeneration in AD since neocortical iron burden predicts Alzheimer’s disease (AD) progression. We found that loss of the presenilins dramatically sensitizes multiple cell types to ferroptosis, but not apoptosis. FAD causal mutations of presenilins similarly sensitizes cells to ferroptosis. The presenilins promote the expression of GPX4, the selenoprotein checkpoint enzyme that blocks ferroptosis by quenching the membrane propagation of lethal hydroperoxyl radicals. Presenilin γ-secretase activity cleaves Notch-1 to signal LRP8 expression, which then controls GPX4 expression by regulating the supply of selenium into the cell since LRP8 is the uptake receptor for selenoprotein P. Selenium uptake is thus disrupted by presenilin FAD mutations, suppressing GPX4 expression. Therefore, presenilin mutations may promote neurodegeneration by derepressing ferroptosis, which has implications for disease-modifying therapeutics. |
format | Online Article Text |
id | pubmed-9613996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96139962022-10-29 Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations Greenough, Mark A. Lane, Darius J. R. Balez, Rachelle Anastacio, Helena Targa Dias Zeng, Zhiwen Ganio, Katherine McDevitt, Christopher A. Acevedo, Karla Belaidi, Abdel Ali Koistinaho, Jari Ooi, Lezanne Ayton, Scott Bush, Ashley I. Cell Death Differ Article Mutations in presenilin 1 and 2 (PS1 and PS2) cause autosomal dominant familial Alzheimer’s disease (FAD). Ferroptosis has been implicated as a mechanism of neurodegeneration in AD since neocortical iron burden predicts Alzheimer’s disease (AD) progression. We found that loss of the presenilins dramatically sensitizes multiple cell types to ferroptosis, but not apoptosis. FAD causal mutations of presenilins similarly sensitizes cells to ferroptosis. The presenilins promote the expression of GPX4, the selenoprotein checkpoint enzyme that blocks ferroptosis by quenching the membrane propagation of lethal hydroperoxyl radicals. Presenilin γ-secretase activity cleaves Notch-1 to signal LRP8 expression, which then controls GPX4 expression by regulating the supply of selenium into the cell since LRP8 is the uptake receptor for selenoprotein P. Selenium uptake is thus disrupted by presenilin FAD mutations, suppressing GPX4 expression. Therefore, presenilin mutations may promote neurodegeneration by derepressing ferroptosis, which has implications for disease-modifying therapeutics. Nature Publishing Group UK 2022-04-21 2022-11 /pmc/articles/PMC9613996/ /pubmed/35449212 http://dx.doi.org/10.1038/s41418-022-01003-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Greenough, Mark A. Lane, Darius J. R. Balez, Rachelle Anastacio, Helena Targa Dias Zeng, Zhiwen Ganio, Katherine McDevitt, Christopher A. Acevedo, Karla Belaidi, Abdel Ali Koistinaho, Jari Ooi, Lezanne Ayton, Scott Bush, Ashley I. Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title | Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title_full | Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title_fullStr | Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title_full_unstemmed | Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title_short | Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations |
title_sort | selective ferroptosis vulnerability due to familial alzheimer’s disease presenilin mutations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613996/ https://www.ncbi.nlm.nih.gov/pubmed/35449212 http://dx.doi.org/10.1038/s41418-022-01003-1 |
work_keys_str_mv | AT greenoughmarka selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT lanedariusjr selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT balezrachelle selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT anastaciohelenatargadias selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT zengzhiwen selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT ganiokatherine selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT mcdevittchristophera selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT acevedokarla selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT belaidiabdelali selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT koistinahojari selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT ooilezanne selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT aytonscott selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations AT bushashleyi selectiveferroptosisvulnerabilityduetofamilialalzheimersdiseasepresenilinmutations |